MDedge Cardiocast is the weekly news podcast from Cardiology News hosted by interventional cardiologist Jim Dwyer, MD. Subscribe now.
Dec 27, 2019
ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative
management of stable ischemic heart disease makes waves.
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in
nondiabetics
Further analyses from the DAPA-HF trial showed dapagliflozin cut
death and heart failure events in HFrEF patients with no
diabetes.
Colchicine cut post-MI CVD events
Colchicine fulfilled the promise first seem in CANTOS that
anti-inflammatory treatment can reduce cardiovascular disease
events.
Getting high heightens stroke, arrhythmia risks
Cannabis use or abuse among the young was associated with adverse
cardiovascular consequences in two studies.
Editor's note: This is the final episode of the MDedge Cardiocast. On behalf of Dr. Jim Dwyer and all of us at MDedge, thank you for supporting Cardiocast.
For more MDedge podcasts, go to www.mdedge.com/podcasts.
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets